Aptargroup, Inc. ATR
We take great care to ensure that the data presented and summarized in this overview for APTARGROUP, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ATR
View all-
Vanguard Group Inc Valley Forge, PA7.21MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.16MShares$905 Million0.02% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL4.74MShares$697 Million0.68% of portfolio
-
Morgan Stanley New York, NY4.74MShares$696 Million0.05% of portfolio
-
State Street Corp Boston, MA2.94MShares$433 Million0.02% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA2.88MShares$424 Million1.22% of portfolio
-
Victory Capital Management Inc1.97MShares$290 Million0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA1.56MShares$229 Million0.02% of portfolio
-
Neuberger Berman Group LLC New York, NY1.27MShares$187 Million0.17% of portfolio
-
Mawer Investment Management Ltd. Calgary, A01.21MShares$178 Million0.89% of portfolio
Latest Institutional Activity in ATR
Top Purchases
Top Sells
About ATR
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Insider Transactions at ATR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2025
|
Marc Prieur Segment President |
BUY
Grant, award, or other acquisition
|
Direct |
1,865
+10.66%
|
-
|
Mar 17
2025
|
Hedi Tlili Segment President |
BUY
Grant, award, or other acquisition
|
Direct |
1,639
+14.86%
|
-
|
Mar 17
2025
|
Hedi Tlili Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
677
-8.03%
|
$98,842
$146.51 P/Share
|
Mar 17
2025
|
Gael Touya Segment President |
BUY
Grant, award, or other acquisition
|
Direct |
1,714
+4.82%
|
-
|
Mar 17
2025
|
Gael Touya Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
790
-2.4%
|
$115,340
$146.51 P/Share
|
Mar 17
2025
|
Daniel Ackerman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
646
+2.32%
|
-
|
Mar 17
2025
|
Xiangwei Gong President, Asia |
BUY
Grant, award, or other acquisition
|
Direct |
1,618
+10.95%
|
-
|
Mar 17
2025
|
Xiangwei Gong President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
529
-4.38%
|
$77,763
$147.84 P/Share
|
Mar 17
2025
|
Kimberly Chainey EVP and Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+14.55%
|
-
|
Mar 17
2025
|
Kimberly Chainey EVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
439
-5.44%
|
$64,533
$147.84 P/Share
|
Mar 17
2025
|
Shiela Vinczeller Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,423
+5.64%
|
-
|
Mar 17
2025
|
Shiela Vinczeller Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-1.47%
|
$48,951
$147.84 P/Share
|
Mar 17
2025
|
Stephan B. Tanda President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,998
+6.17%
|
-
|
Mar 17
2025
|
Stephan B. Tanda President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,454
-1.99%
|
$507,738
$147.84 P/Share
|
Mar 17
2025
|
Vanessa Kanu EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,767
+32.21%
|
-
|
Mar 14
2025
|
Xiangwei Gong President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-3.59%
|
$65,554
$146.66 P/Share
|
Mar 14
2025
|
Gael Touya Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-2.03%
|
$98,745
$145.23 P/Share
|
Mar 14
2025
|
Hedi Tlili Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
559
-6.22%
|
$81,055
$145.23 P/Share
|
Mar 14
2025
|
Kimberly Chainey EVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-4.41%
|
$54,312
$146.66 P/Share
|
Mar 14
2025
|
Stephan B. Tanda President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,783
-1.58%
|
$406,318
$146.66 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 99.7K shares |
---|---|
Exercise of conversion of derivative security | 121K shares |
Payment of exercise price or tax liability | 39.3K shares |
---|---|
Open market or private sale | 148K shares |
Bona fide gift | 2.18K shares |